Skip to content
Enzyme logo

Enzyme

Enzyme is a YC Summer 2017 (S17) company. Based in San Francisco, CA, USA; Remote. Team of 32.

  • SaaS

About Enzyme

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Enzyme builds cloud-based quality management system software for medical device, digital health, and biopharma companies navigating FDA approval and ongoing regulatory compliance. The platform covers document control, change control, risk management, CAPA, audits, and the full premarket-to-postmarket lifecycle, replacing the manual processes and disconnected tools that life science teams typically cobble together. Enzyme also provides QA and RA consulting to support companies through the regulatory process directly.

Business model

Subscription-based SaaS with optional QA/RA consulting services.

Go-to-market

Life science companies, from early-stage startups to IPO-stage firms, adopt the platform via a sales-led motion with demo-request entry points on the website.

From the Y Combinator listing

How Enzyme describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Automating regulatory approval & compliance for life science companies

Enzyme provides online quality management system software and supportive QA/RA consulting, helping life science companies with FDA approval and ongoing compliance. Enzyme staff has over 50 years of medical device industry experience, across several Fortune 500 companies and startups.

Facts

Industry
Healthcare / Healthcare -> Healthcare IT
Location
San Francisco, CA, USA; Remote
Team size
32
Status
Acquired
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works